Fund Holdings — Darwin Global Management, Ltd.

Total Portfolio Value
$3.77B
Total Bought
$504.41M
Total Sold
$1.44B
Net Transaction
-$931.81M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
REVOLUTION MEDICINES INC(RVMD)02,211,018+2,211,0180204,9835.44%+204,983
ROIVANT SCIENCES LTD(ROIV)06,797,300+6,797,3000179,5174.76%+179,517
DIANTHUS THERAPEUTICS INC(DNTH)017,357+17,35701,4570.04%+1,457
CAPRICOR THERAPEUTICS INC(CAPR)800,0000-800,00023,1680—-23,168
BELITE BIO INC(BLTE)3,027,7043,057,412+29,708486,915456,10512.10%-30,811
ABIVAX SA(ABVX)3,178,5013,468,657+290,156439,714352,0699.34%-87,645
WAVE LIFE SCIENCES LTD(WVE)7,298,4210-7,298,421125,1680—-125,168
CIDARA THERAPEUTICS INC997,1960-997,196220,1810—-220,181
INSMED INC(INSM)20,933,27716,805,184-4,128,0933,644,2742,576,57168.33%-1,067,703
Page 1 of 1
Darwin Global Management, Ltd. — 13F Holdings — Q1 2026 | TickerTrail